Shane V. Hegarty

Chief Scientific Officer & Co-Founder

Previously
Research Fellow, Boston Children’s Hospital, Harvard Medical School
Neuroscience Faculty, University College Cork, Ireland
Neuroscience Ireland Investigator Award 2016

Shane V. Hegarty

Chief Scientific Officer & Co-Founder

Previously
Research Fellow, Boston Children’s Hospital, Harvard Medical School
Neuroscience Faculty, University College Cork, Ireland
Neuroscience Ireland Investigator Award 2016

Dr Shane Hegarty is Chief Scientific Officer, Co-Founder and IP Co-Inventor at AXONIS Therapeutics, a Boston-based biotechnology company. He has 15+ years of experience leading cutting-edge, award-winning neuro-protection, -modulation and -regeneration research for neurological disorders. In recent years, Shane has completed a number of competitive biotech entrepreneurial programs, such as Creative Destruction Labs and Harvard I-Labs. As a Research Fellow in Professor Zhigang He’s lab in Boston Children’s Hospital and Harvard Medical School, Dr. Hegarty led in vivo phenotypic screens, such as a genome-wide AAV-CRISPR screen for neuro-protection and -regeneration in a CNS injury model.

Before leaving a tenure-track position in Ireland to pursue cutting-edge research in the US, he was a Faculty Member in Neuroscience Department of University College Cork, and received the prestigious Neuroscience Ireland Investigator Award in 2016. During his academic career, Dr. Hegarty was awarded several highly-competitive scholarships and fellowships to support independent research, including from the Irish Research Council, National University of Ireland and William Randolph Hearst Foundation. A Royal Irish Academy grant supported post-doctoral training in the Erasmus MC, Netherlands and KU Leuven, Belgium. A highly productive researcher with 30+ research papers (22 as first/senior author), >1,400 citations, several patents, h-index = 18, and a serial grant awardee. Dr. Hegarty has acted as an Editor for Frontiers and The Biochemist, and expert reviewer for a number of esteemed journals and international funding agencies. An experienced entrepreneur, innovator, researcher, team builder and teacher, who graduated top of his Neuroscience BSc class.

Dr. Hegarty has dedicated his entire career towards developing new therapies for patients with neurological disorders.

Scroll to Top